INCY 15 (Jakafi 15 mg)

Generic Name: ruxolitinib

Pill imprint INCY 15 has been identified as Jakafi 15 mg.

Jakafi is used in the treatment of myelofibrosis; myeloproliferative disorders and belongs to the drug class multikinase inhibitors. Risk cannot be ruled out during pregnancy. Jakafi 15 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for INCY 15 (Jakafi 15 mg)

Jakafi 15 mg INCY 15
Jakafi
Generic Name:
ruxolitinib
Imprint:
INCY
15
Strength:
15 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Incyte Corporation
National Drug Code (NDC):
50881-0015
Inactive Ingredients:
microcrystalline cellulose
lactose monohydrate
silicon dioxide
hydroxypropyl cellulose
povidone
sodium starch glycolate type A potato
magnesium stearate

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web4)